EMILIN1 and neoplasm: Proteomic analyses reveal elevated EMILIN-1 levels in serum-derived EVs from mucinous colon adenocarcinomas (a clinically aggressive subtype) [49], suggesting either compensatory tumor-suppressor mobilization or pathologic co-option of vesicular transport.